$3.30
3.13%
Nasdaq, Jan 02, 10:04 pm CET
ISIN
US7163821066
Symbol
PETS

PetMed Express, Inc. Stock price

$3.30
+1.57 90.75% 1M
-0.07 2.08% 6M
+0.10 3.13% YTD
-1.34 28.88% 1Y
-14.40 81.36% 3Y
-29.54 89.95% 5Y
-13.45 80.30% 10Y
-9.71 74.64% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
+0.10 3.13%

Key metrics

Basic
Market capitalization
$70.5m
Enterprise Value
$15.8m
Net debt
positive
Cash
$54.7m
Shares outstanding
20.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.3 | 0.3
EV/Sales
0.1 | 0.1
EV/FCF
negative
P/B
0.8
Dividends
DPS
$0.60
Yield 1Y | 5Y
18.2% | 4.6%
Growth 1Y | 5Y
-50.0% | -10.8%
Payout 1Y | 3Y
-162.2% | 441.2%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$227.0m | $203.0m
EBITDA
$7.6m | $5.7m
EBIT
$538.0k | $-5.8m
Net Income
$-6.3m | $-4.6m
Free Cash Flow
$-400.0k
Growth (TTM | estimate)
Revenue
-19.3% | -10.5%
EBITDA
413.2% | -15.1%
EBIT
105.7% | -1,668.9%
Net Income
21.6% | 26.0%
Free Cash Flow
-110.5%
Margin (TTM | estimate)
Gross
30.5%
EBITDA
3.3% | 2.8%
EBIT
0.2%
Net
-2.8% | -2.3%
Free Cash Flow
-0.2%
Financial Health
Equity Ratio
57.3%
Return on Equity
-7.4%
ROCE
0.6%
ROIC
8.4%
Debt/Equity
0.0
More
EPS
$-0.3
FCF per Share
$0.0
Short interest
17.1%
Employees
287
Rev per Employee
$790.0k
Show more

Is PetMed Express, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

PetMed Express, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a PetMed Express, Inc. forecast:

2x Hold
33%
4x Sell
67%

Analyst Opinions

6 Analysts have issued a PetMed Express, Inc. forecast:

Hold
33%
Sell
67%

Financial data from PetMed Express, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
227 227
19% 19%
100%
- Direct Costs 158 158
22% 22%
70%
69 69
12% 12%
30%
- Selling and Administrative Expenses 62 62
24% 24%
27%
- Research and Development Expense - -
-
-
7.58 7.58
413% 413%
3%
- Depreciation and Amortization 7.04 7.04
0% 0%
3%
EBIT (Operating Income) EBIT 0.54 0.54
106% 106%
0%
Net Profit -6.27 -6.27
22% 22%
-3%

In millions USD.

Don't miss a Thing! We will send you all news about PetMed Express, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PetMed Express, Inc. Stock News

Neutral
Business Wire
18 days ago
MIAMI--(BUSINESS WIRE)--Cardone Ventures, backed by billionaire investor, Grant Cardone and his business partners Brandon and Natalie Dawson, today announced that it has submitted an unsolicited, non-binding proposal to acquire PetMed Express, Inc. (Nasdaq: PETS) (“PetMeds”) for $4.25 per share in cash, representing an implied equity value of approximately $89 million. The proposal was delivere...
Neutral
GlobeNewsWire
23 days ago
DELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company” or “PetMeds”), today confirmed that it has received an unsolicited and non-binding acquisition proposal from SilverCape Investments Limited, a Singapore-based investment firm, to acquire all of the outstanding shares of the Company for $4 per s...
Neutral
GlobeNewsWire
25 days ago
DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today unveiled its new Holiday Collection, a curated selection of health, wellness, and lifestyle products designed for pet parents who want to give purposeful, practical gifts this season. Unlike traditional pet gifts such as toys or beds, P...
More PetMed Express, Inc. News

Company Profile

PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail or print advertising campaigns. The company was founded in January 1996 and is headquartered in Delray Beach, FL.

Head office United States
CEO Sandra Campos
Employees 287
Founded 1996
Website www.1800petmeds.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today